The offer is made with a view to delist and privatise the company.
UOB Kay Hian analyst Llelleythan Tan has advised Singapore Medical Group’s (SMG) shareholders to reject the group’s offer.
On Sept 13, SMG’s CEO, non-executive chairman and executive director made a conditional general offer of 37 cents per share to the group’s shareholders.
